Skip to main content
Equibles
LUCY logo

LUCY · Innovative Eyewear Inc · Financials

Track LUCY — free

Use LUCY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LUCY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.91 +0.02 (+2.46%)
Rebalance outlook locked
Market Cap
$7.90M
Shares
8.61M
Volume · Oct 6 404.89K Avg daily vol (3M) 7.61M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Pull these statements through the financial statements API or MCP →
Revenue
$2.66M +62.6%
FY2025 Revenue FY2021–FY2025
Net Income
-$7.59M +2.3%
FY2025 Net Income FY2021–FY2025
Gross Margin
21.32% +8.2pp
FY2025 Gross Margin FY2021–FY2025
Diluted EPS
-$1.90 +63.4%
FY2025 Diluted EPS FY2022–FY2025
Operating Cash Flow
-$7.28M -7.9%
FY2025 Operating Cash Flow FY2021–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021
$3.41M $2.66M $1.64M $1.15M $659.79K $690.67K
$2.63M $2.09M $1.42M $1.27M $716.08K $542.42K
$777.54K $567.45K $215.19K -$119.33K -$56.29K $148.25K
— 21.32% 13.15% -10.35% -8.53% 21.47%
$526.79K $725.39K $819.39K $662.18K $524.69K $86.26K
$2.98M $2.97M $2.71M $2.05M $2.06M $1.77M
$5.63M $5.23M $4.47M $3.89M $2.8M $1.39M
$71.56K $68.55K $39.9K $24.16K $10.47K $7179
$48.4K $66.79K $109.49K $61.09K $22.1K $498
$9.27M $9.06M $8.14M $6.74M $5.52M $3.35M
— — — $3036 $105.17K $39.43K
$810.25K $903.78K $157.19K $192.11K -$105.17K —
-$7.69M -$7.59M -$7.77M -$6.66M -$5.68M -$3.24M
— -285.2% -474.6% -578.18% -861.16% -469.76%
USD/shares -$1.15 -$1.90 -$5.19 -$10.87 -$17.40 —
USD/shares -$1.15 -$1.90 -$5.19 -$10.87 -$17.40 —
shares — 3.99M 1.5M 613K — —
shares — 3.99M 1.5M 613K 326.45K —
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
—
Peer median 0.76×
EV/EBIT
—
P/E (TTM)
—

Peer medians compare against the 11 similar-size Medical Instruments & Supplies companies (of 47 listed).

Key facts CIK 1808377 Visit website Investor relations